期刊文献+

β-环糊精聚乙二醇羟基喜树碱高聚物的合成及其载药量研究 被引量:3

Synthesis of polymer β-CD-PEG-HCPT and its drug loading capacity
原文传递
导出
摘要 目的合成β-环糊精聚乙二醇羟基喜树碱高聚物(β-CD-PEG-HCPT)并研究其载药量。方法以β-环糊精和4-4′联苯二磺酰氯为起始原料,通过酰化反应、碘代反应、取代反应、酰化反应得到聚乙二醇-β-环糊精(β-CD-PEG)。采用羟基喜树碱(HCPT)为起始原料,利用乙酰基对10位羟基进行保护,再利用二氯甲烷/甲醇/乙酰氯这种温和的系统脱去乙酰基,得到乙酰羟基喜树碱甘氨酸酯(Ac-HCPT-Gly)。β-CD-PEG和Ac-HCPT-Gly反应得到目标产物β-CD-PEG-HCPT。结果合成了目标产物β-CD-PEG-HCPT,其结构通过1H-NMR确证。HCPT的载药量是4.3%。结论改进了β-CD-PEG-HCPT的合成工艺,操作简单、成本低、收率较高。 Objective To synthesize β-CD-PEG-HCPT and study its drug loading capacity. Methods β-Cyclodextrin(β-CD) and biphenyl-4,4'-disulfonyl chloride were used as the starting materials to synthesize β-CD-PEG by acylation reaction, iodination reaction, substitution reaction, and acylation reaction. HCPT was used as the starting materials, and 10-OH of HCPT was protected by the acetyl group and deprotected by the system of CH2 Cl2/CH3 OH/acetyl chloride to synthesize Ac-HCPT-Gly. β-CD-PEG and Ac-HCPT-Gly were reacted to synthesize the target compound β-CD-PEG-HCPT. Results The target compound β-CD-PEG-HCPT was synthesized, and the structure has been confirmed by 1 H-NMR. The drug loading of HCPT was 4.3%. Conclusion This study improves the synthesis process ofβ-CD-PEG-HCPT with simple operation, low cost, and high yield.
作者 孙勇兵 黄花 胡律江 郭晓秋 胡志方 SUN Yong-bing;HUANG Hua;HU Lü-jiang;GUO Xiao-qiu;HU Zhi-fang(National Engineering Research Center for Solid Preparation Technology of Chinese Medicine,Jiangxi University of Traditional Chinese Medicine,Nanchang 330006,China;The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,China;Jiangxi College of Traditional Chinese Medicine,Fuzhou 344000,China)
出处 《现代药物与临床》 CAS 2018年第8期1859-1864,共6页 Drugs & Clinic
基金 国家自然科学基金资助项目(81360485 81560577) 江西省卫计委中医药课题(2017Z014 2017A322) 江西省教育厅科研课题(20181110)
关键词 β-环糊精聚乙二醇羟基喜树碱高聚物 Β-环糊精 羟基喜树碱 聚乙二醇 高聚物 β-CD-PEG-HCPT HCPT β-CD PEG high molecular weight polymer
  • 相关文献

参考文献2

二级参考文献17

  • 1周永刚,孟广森,胡淑雅.高效液相-荧光检测法测定羟基喜树碱血浓度[J].中国药师,2004,7(9):702-703. 被引量:4
  • 2方芸,张海霞,谈恒山.雾化吸入与静脉注射羟基喜树碱在兔体内的药动学比较[J].中国药学杂志,2006,41(16):1255-1258. 被引量:6
  • 3Zhang R,Li Y,Cai Q,et al.Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin,an inhibitor of topoisomerase I[J].Cancer Chemother Pharmacol,1998,41(4):2657~2671.
  • 4Ma J,Liu CL,Zhu PL,et al.Simultaneous determination of the carboxylate and lactone forms of 10-hydroxycamptothecin in human serum by restricted-access media high-performance liquid chromatography [J].J Chromatogr B,2002,772:197~204.
  • 5Zhou JJ,Liu Jn,Xu B.Relationship between lactone ring forms of HCPT and their antitumor activities[J].Chinese pharmacological Journal,2001,22(9):827~830.
  • 6SLICHEMYER WJ,ROWINSKY EK, DONEHOWER RC, et al. The current status of camptothecin analoguesasant itumoragent [J]. J Natl Cancer Inst, 1993, 85(4) : 271-291.
  • 7POTMESIL M. Camptothecins: Form bench research to hospital wards[J]. CancerRes, 1994, 54(6) : 1431-1439.
  • 8OGUMA T, OHSHIMA Y, NAKAOKA M. Sensitive high-performance liquid chromatographic method for the determination of the lactone form and the lactone plus hydroxy-acid forms of the new camptothecin derivative DX-8951 in human plasma using fluore-scence detection [J]. J Chromatogr B Biomed Sci Appl, 2000,740(2): 237-245.
  • 9RIVORY LP, FINDLAY M, CLARKE S, et al. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography[J]. J Chromatogr B , 1998, 714(2): 355-359.
  • 10WARNER DL, BURKE TG. Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs[J].J Chromatogr B, 1997, 619(1):161-171.

共引文献8

同被引文献41

引证文献3

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部